Bifemelane hydrochloride

Key Product Details

Product Description

Bifemelane hydrochloride is an antidepressant MAO inhibitor. Reverses catalepsy induced by Tetrabenazine (Cat. No. 2175) in mice and increases locomotor activity in MPTP-treated marmosets.

Product Specifications for Bifemelane hydrochloride

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Solubility

Preparing Stock Solutions for Bifemelane hydrochloride

The following data is based on the product molecular weight 305.84.

Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:

2 1 Recalculate

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	3.27 mL	16.35 mL	32.70 mL
5 mM	0.65 mL	3.27 mL	6.54 mL
10 mM	0.33 mL	1.63 mL	3.27 mL
50 mM	0.07 mL	0.33 mL	0.65 mL

Calculators

Background References

References are publications that support the biological activity of the product.

• Nomoto Effects of bifemelane on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset. Neurosci.Lett. 1994 PMID: 7816348
• Tobe Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCl-2016), a new psychotropic drug with antidepressant activity. Arzneimittelforschung 1981 PMID: 7197535
• Naoi 4-(o-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(o-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase. J.Neurochem. 1988 PMID: 3335842

Product Documents for Bifemelane hydrochloride